Kalaris Therapeutics Announces Additional Data From Its Phase 1A Trial Of TH103 In Neovascular Age-Related Macular Degeneration; Additional Patients Showed Improvements In Vision And Retinal Anatomy

뉴스 본문을 불러오고 있어요.

Kalaris Therapeutics Announces Additional Data From Its Phase 1A Trial Of TH103 In Neovascular Age-Related Macular Degeneration; Additional Patients Showed Improvements In Vision And Retinal Anatomy | 웨이프 WAPE

Kalaris Therapeutics Announces Additional Data From Its Phase 1A Trial Of TH103 In Neovascular Age-Related Macular Degeneration; Additional Patients Showed Improvements In Vision And Retinal Anatomy

기사 요약

관련 종목

댓글 —